COMBINING A PATIENT’S OPTIMIZED DENDRITIC CELLS (POTENT IMMUNE STIMULATORS) WITH POOLED AND WELL-CHARACTERIZED LYSATES FROM OTHER PATIENT’S BRAIN TUMOR CULTURES TO GENERATE AN ANTI-TUMOR VACCINE INCORPORATING NEW METHODS FOR MONITORING CHANGES IN THE IMMUNE SYSTEM. PROJECT EXPANDED IN 2014 TO INCREASE THE NUMBER OF PATIENTS TO PROVIDE STRONG STATISTICAL CONFIRMATION OF RESULTS AS WELL AS INCLUDE PATIENTS WITH RELAPSED GLIOBLASTOMA TO THE STUDY.